These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 21122095)

  • 1. Long-Term follow up after intra-Uterine transfusionS; the LOTUS study.
    Verduin EP; Lindenburg IT; Smits-Wintjens VE; van Klink JM; Schonewille H; van Kamp IL; Oepkes D; Walther FJ; Kanhai HH; Doxiadis II; Lopriore E; Brand A
    BMC Pregnancy Childbirth; 2010 Dec; 10():77. PubMed ID: 21122095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term neurodevelopmental outcome after intrauterine transfusion for hemolytic disease of the fetus/newborn: the LOTUS study.
    Lindenburg IT; Smits-Wintjens VE; van Klink JM; Verduin E; van Kamp IL; Walther FJ; Schonewille H; Doxiadis II; Kanhai HH; van Lith JM; van Zwet EW; Oepkes D; Brand A; Lopriore E;
    Am J Obstet Gynecol; 2012 Feb; 206(2):141.e1-8. PubMed ID: 22030316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High anti-HLA response in women exposed to intrauterine transfusions for severe alloimmune hemolytic disease is associated with mother-child HLA triplet mismatches, high anti-D titer, and new red blood cell antibody formation.
    Verduin EP; Schonewille H; Brand A; Haasnoot GW; Claas FH; Lindenburg IT; Lopriore E; Oepkes D; Roelen DL; Doxiadis II
    Transfusion; 2013 May; 53(5):939-47. PubMed ID: 22924899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors associated with persistence of red blood cell antibodies in woman after pregnancies complicated by fetal alloimmune haemolytic disease treated with intrauterine transfusions.
    Verduin EP; Brand A; van de Watering LM; Claas FH; Oepkes D; Lopriore E; Doxiadis II; Schonewille H
    Br J Haematol; 2015 Feb; 168(3):443-51. PubMed ID: 25244566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurodevelopmental outcome in twin anemia-polycythemia sequence after laser surgery for twin-twin transfusion syndrome.
    Slaghekke F; van Klink JM; Koopman HM; Middeldorp JM; Oepkes D; Lopriore E
    Ultrasound Obstet Gynecol; 2014 Sep; 44(3):316-21. PubMed ID: 24753027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severity of haemolytic disease of the fetus and newborn in patients with a history of intrauterine transfusions in a previous pregnancy: A nationwide retrospective cohort study.
    Van't Oever RM; Zwiers C; de Haas M; le Cessie S; Lopriore E; Oepkes D; Verweij EJTJ
    BJOG; 2024 May; 131(6):769-776. PubMed ID: 37743689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management and clinical consequences of red blood cell antibodies in pregnancy: A population-based cohort study.
    Liu S; Ajne G; Wikman A; Lindqvist C; Reilly M; Tiblad E
    Acta Obstet Gynecol Scand; 2021 Dec; 100(12):2216-2225. PubMed ID: 34476807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful management of severe red blood cell alloimmunization in pregnancy with a combination of therapeutic plasma exchange, intravenous immune globulin, and intrauterine transfusion.
    Nwogu LC; Moise KJ; Klein KL; Tint H; Castillo B; Bai Y
    Transfusion; 2018 Mar; 58(3):677-684. PubMed ID: 29250791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neonatal outcomes following intrauterine transfusion for hemolytic disease of the fetus and newborn: a twenty-year service review.
    Blyth U; Larsson M; Baird A; Waring G; Athiraman N
    J Matern Fetal Neonatal Med; 2022 Dec; 35(25):10220-10225. PubMed ID: 36121063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting Intrauterine Transfusion Interval and Perinatal Outcomes in Alloimmunized Pregnancies: Time-to-Event Survival Analysis.
    Snelgrove JW; D'Souza R; Seaward PGR; Windrim R; Kelly EN; Ryan G
    Fetal Diagn Ther; 2019; 46(6):425-432. PubMed ID: 31195389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perinatal Outcome and Long-Term Neurodevelopment after Intracranial Haemorrhage due to Fetal and Neonatal Alloimmune Thrombocytopenia.
    Winkelhorst D; Kamphuis MM; Steggerda SJ; Rijken M; Oepkes D; Lopriore E; van Klink JMM
    Fetal Diagn Ther; 2019; 45(3):184-191. PubMed ID: 29730660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. School performance and behavioral functioning in children after intrauterine transfusions for hemolytic disease of the fetus and newborn.
    Ree IMC; van 't Oever RM; Jansen L; Lopriore E; de Haas M; van Klink JMM
    Early Hum Dev; 2021 Jun; 157():105381. PubMed ID: 33962361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fetal and neonatal outcome in severe alloimmunization managed with intrauterine transfusion: 18-year experience in a tertiary referral hospital in China.
    Pan W; Wu H; Chen J; Mo X; Wang H; Fang Q; Li Y; Huang Y
    Front Pediatr; 2023; 11():1157004. PubMed ID: 37124190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complications of intrauterine intravascular blood transfusion: lessons learned after 1678 procedures.
    Zwiers C; Lindenburg ITM; Klumper FJ; de Haas M; Oepkes D; Van Kamp IL
    Ultrasound Obstet Gynecol; 2017 Aug; 50(2):180-186. PubMed ID: 27706858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurodevelopmental outcome at 2 years in twin-twin transfusion syndrome survivors randomized for the Solomon trial.
    van Klink JM; Slaghekke F; Balestriero MA; Scelsa B; Introvini P; Rustico M; Faiola S; Rijken M; Koopman HM; Middeldorp JM; Oepkes D; Lopriore E
    Am J Obstet Gynecol; 2016 Jan; 214(1):113.e1-7. PubMed ID: 26297943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intrauterine Blood Transfusion for Parvo B19-Induced Fetal Anemia: Neuroimaging Findings and Long-Term Neurological Outcomes.
    Berezowsky A; Hochberg A; Regev N; Weisz B; Lipitz S; Yinon Y
    Fetal Diagn Ther; 2023; 50(3):206-214. PubMed ID: 37231949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemolytic disease of the fetus and newborn: systematic literature review of the antenatal landscape.
    de Winter DP; Kaminski A; Tjoa ML; Oepkes D
    BMC Pregnancy Childbirth; 2023 Jan; 23(1):12. PubMed ID: 36611144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High additional maternal red cell alloimmunization after Rhesus- and K-matched intrauterine intravascular transfusions for hemolytic disease of the fetus.
    Schonewille H; Klumper FJ; van de Watering LM; Kanhai HH; Brand A
    Am J Obstet Gynecol; 2007 Feb; 196(2):143.e1-6. PubMed ID: 17306657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term neurodevelopmental and cardiovascular outcome after intrauterine transfusions for fetal anaemia: a review.
    Lindenburg IT; van Klink JM; Smits-Wintjens VE; van Kamp IL; Oepkes D; Lopriore E
    Prenat Diagn; 2013 Sep; 33(9):815-22. PubMed ID: 23658134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome predictors for maternal red blood cell alloimmunisation with anti-K and anti-D managed with intrauterine blood transfusion.
    Vlachodimitropoulou E; Garbowski M; Anne Solomon S; Abbasi N; Seaward G; Windrim R; Keunen J; Kelly E; Van Mieghem T; Shehata N; Ryan G
    Br J Haematol; 2022 Feb; 196(4):1096-1104. PubMed ID: 34862601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.